PharmEasy news & insights

PharmEasy just sold another slice of Thyrocare. It may be the last one.

API Holdings could be debt-free within days. That clears the first of two conditions standing between PharmEasy and a reverse merger into Thyrocare — …

All Home Raises ₹200 Cr: PharmEasy Founders' New Bet

API Holdings FY26 Financial Analysis: PharmEasy's EBITDA Turnaround

Thyrocare’s Best Profit Year Ever – FY26 Results

API Holdings Q3 FY26 Results: From Cash Burn to Cost Control

PharmEasy’s Lifeline? Docon Offloads 10% Stake in Thyrocare for ₹668 Crore — Can API Holdings Stage a FY26 Turnaround?

PharmEasy’s parent, API Holdings, has been struggling for the last two years with tight liquidity, debt refinancing challenges, and delayed IPO …

PharmEasy’s Fresh Debt Raise: A Deeper Look into the ₹1,700 Crore Move

Introduction PharmEasy, one of Mumbai’s leading health-tech unicorns, has taken a decisive financial step by raising ₹1,700 crore in a debt roun…

PharmEasy CEO Siddharth Shah Steps Down; Rahul Guha Appointed New MD & CEO of API Holdings

In a major leadership transition at API Holdings, the parent company of digital health unicorn PharmEasy, co-founder and CEO Siddharth Shah has steppe…

All Home: PharmEasy Founders' New Disruptive Venture in India's Interior Design Market

Executive Summary All Home, founded by the core team behind PharmEasy, is revolutionizing India's $30B+ interior design industry. The startup, now val…

PharmEasy Ups Diagnostic Game with 'On-Time or Free' Promise

PharmEasy, one of India's leading digital healthcare platforms, has launched a fresh marketing campaign designed to drive adoption and trust in its di…

PharmEasy’s Struggles and Investment Returns: A Look into Prosus’ Portfolio Performance

In the first half of the fiscal year, online pharmacy startup PharmEasy delivered disappointing results for global investment firm Prosus, posting an …